Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.' Baby Tam' Effective, Tolerable for Breast Cancer Prevention'Baby Tam' Effective, Tolerable for Breast Cancer Prevention
Lower-dose tamoxifen aims to reduce those side effects, but there remains some uncertainty about the minimum dose required to maintain efficacy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Few With Inflammatory Breast Cancer Get Guideline-Based Care Few With Inflammatory Breast Cancer Get Guideline-Based Care
A US study finds a surprisingly low rate of guideline-concordant care in women with inflammatory breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Sickle Cell: Good Outcomes for Haploidentical Transplants Sickle Cell: Good Outcomes for Haploidentical Transplants
It is much easier to find eligible haploidentical donors — half-matched or partially matched — than eligible hematopoietic donors.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Mantle Cell Lymphoma: Drug Combo Improves PFS Mantle Cell Lymphoma: Drug Combo Improves PFS
' In the countries where ibrutinib is indicated, this combination should be a new standard therapy for relapsed/refractory mantle cell lymphoma. 'MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Europe Approves Avapritinib for Rare Mast Cell Disease Europe Approves Avapritinib for Rare Mast Cell Disease
The drug targets a mast cell mutation that gives rise to indolent systemic mastocytosis, a rare and debilitating blood disorder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Supercharge Your Medical Practice With ChatGPT Supercharge Your Medical Practice With ChatGPT
An expert on artificial intelligence in oncology describes why, and how, to integrate ChatGPT into your clinical practice.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Myeloma: Isatuximab 4-Drug Regimen Boosts MRD Negativity Myeloma: Isatuximab 4-Drug Regimen Boosts MRD Negativity
' This [research] builds on our experience that four-drug combinations with a monoclonal antibody, proteasome inhibitor, immunomodulatory drug, and steroids are superior to three-drug combinations. 'MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
The Unknowns of Taxanes for Breast Cancer During Pregnancy The Unknowns of Taxanes for Breast Cancer During Pregnancy
Taxane exposure during pregnancy appears to be safe for mothers and offspring, according to a new retrospective cohort analysis.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
MRD Status Predicts Transplant Benefit in NPM1-Mutated AML MRD Status Predicts Transplant Benefit in NPM1-Mutated AML
MRD-positive patients in first complete remission after induction therapy had a survival benefit after transplant; however, that benefit did not extend to MRD-negative patients after transplant.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Women 50+ May Safely Reduce Mammogram Frequency Post-Surgery Women 50+ May Safely Reduce Mammogram Frequency Post-Surgery
Women aged 50 and older who have undergone curative treatment for breast cancer and remain cancer free after 3 years may safely deescalate mammogram surveillance.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Measurable Residual Disease-Guided Therapy Promising in CLL Measurable Residual Disease-Guided Therapy Promising in CLL
The ibrutinib-venetoclax combination was particularly effective in patients with chronic lymphocytic leukemia with high-risk features such as IGHV unmutated disease or chromosomal abnormalities.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T
' In patients with relapsed DLBCL in a complete remission, treatment with auto-HCT is associated with a lower rate of relapse/progression, and a longer progression-free survival [versus CAR T therapy]. 'MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Distinct Toxicity Profiles for Anti-BCMA Myeloma Therapies Distinct Toxicity Profiles for Anti-BCMA Myeloma Therapies
CAR T cells directed against the B-cell maturation antigen (BCMA) are linked to systemic and neurological side effects, while the antibody teclistamab is associated with increased infection risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Living in a Food Swamp Tied to High Breast Cancer Mortality Living in a Food Swamp Tied to High Breast Cancer Mortality
New research shows higher postmenopausal breast cancer mortality in communities with easier access to unhealthy fast food.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Study Eyes Melanoma Characteristics in AI/AN Population Study Eyes Melanoma Characteristics in AI/AN Population
The primary site with the highest mortality risk was the trunk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 11, 2023 Category: Cancer & Oncology Tags: Dermatology Source Type: news
